RECRO PHARMA INC

CUSIP: 75629F109 Class: COMMON

ROYCE & ASSOCIATES LP's Holding History (CIK: 0000906304)

Note: Option positions (PUT/CALL) are excluded.

Q4 2023
Shares 3,293,382 Value ($000) $1,154 Avg Close — Range —
Q3 2023
Shares 3,285,082 Value ($000) $1,541 Avg Close — Range —
Q2 2023
Shares 2,526,078 Value ($000) $2,779 Avg Close — Range —
Q1 2023
Shares 1,986,725 Value ($000) $2,364 Avg Close — Range —
Q4 2022
Shares 1,775,000 Value ($000) $2,645 Avg Close — Range —